drugset / Trial / NCT06595004
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-blind, Active-controlled, Non-inferiority, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HCP1004 as compared to RLD2401 in Chronic Low-Back Pain Patients
Timeline
- Start
- 2024-11-22
- Primary completion
- 2025-06-18
- Completion
- 2025-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCP1004 | Unknown | — | Oral |
| Comparator | RLD2401 | Unknown | — | Oral |